热景生物6月9日龙虎榜 6月9日热景生物（688068）收盘价161.15元，收盘上涨18.15%，全天换手率6.41%，振幅24.46%，成交 额9.02亿元。科创板交易公开信息显示，当日该股因日收盘价涨幅达15%等上榜。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交3.79亿元， 其中，买入成交额为2.37亿 元，卖出成交额为1.42亿元，合计净买入9503.95万元。具体来看，今日上榜的前五大买入营业部中，有 3家机构专用席位现身，即买一、买四、买五，买入金额分别为8867.62万元、3117.17万元、2460.83万 元，营业部合计买入9260.57万元。卖出营业部中，有1家机构专用席位现身，即卖二，卖出金额分别为 3442.21万元，营业部合计卖出1.08亿元。买卖金额相抵，机构专用席位今日净买入该股1.10亿元。 资金流向方面，该股今日全天主力资金净流入5174.91万元。（数据宝） | 买入营业部名称 | 买入金额(万元) | | --- | --- | | 机构专用 | 8867.62 | | 国盛证券有限责任公司深圳粤海街道证券营业部 | 4746.58 | | 高盛(中国)证 ...

中国经济网北京6月6日讯热景生物(688068.SH)昨日晚间披露关于股东减持计划完成暨减持股份结果公告。 热景生物于2025年3月22日披露了《北京热景生物技术股份有限公司股东减持股份计划公告》，股东青岛同程热景企业管理 咨询合伙企业(有限合伙)(以下简称"同程热景")因自身资金需求，计划通过集中竞价、大宗交易方式减持所持有公司股份合 计不超过1,800,000股，占公司当时总股本的1.9465%。 热景生物的控股股东、实际控制人、董事长、总经理林长青系同程热景的执行事务合伙人和普通合伙人。根据热景生物 2024年年报显示，林长青直接持有公司23.4469%的股权，通过同程热景间接持有公司0.9640%的股权，为公司的实际控制 人。 2024年，热景生物营业总收入为51,089.06万元，同比减少7.62%；归属于母公司所有者的净利润-17,923.07万元，2023年同 期为2,851.62万元；归属于母公司所有者的扣除非经常性损益的净利润为-24,315.82万元，2023年同期-5,819.66万元。 热景生物于2019年9月30日在上交所科创板上市，发行数量为15,550,000股(无老股转让)，发 ...

Group 1 - Aike Technology (688092.SH) shareholders plan to reduce their holdings by up to 826,906 shares, accounting for 1.00% of the total share capital within three months after 15 trading days from the announcement [1] - Aike Cyber (688719.SH) executives plan to reduce their holdings by up to 2.1927% of the total share capital, totaling 2,530,000 shares within three months after 15 trading days from the announcement [1] - Anpeilong (301413.SZ) shareholders plan to reduce their holdings by up to 2,952,058 shares, representing 3% of the total share capital [1] Group 2 - Chaohongji (002345.SZ) shareholders plan to reduce their holdings by up to 26,655,380 shares, accounting for 3% of the total share capital within three months after 15 trading days from the announcement [2] - Chunguang Technology (603657.SH) plans to reduce its holdings by up to 1,000,000 shares, representing 0.73% of the total share capital [2] - Dahongli (300865.SZ) controlling shareholder plans to reduce his holdings by 136,150 shares, accounting for 1.4230% of the total share capital [2] Group 3 - Electric Link Technology (300679.SZ) executives plan to reduce their holdings by specified amounts, with individual reductions not exceeding 15,000 to 78,000 shares [2] - Guangge Technology (688450.SH) shareholders plan to reduce their holdings by a total of 990,000 shares, representing 1.50% of the total share capital [2] - Guorui Technology (300600.SZ) shareholders plan to reduce their holdings by 8,827,034 shares, accounting for 3% of the total share capital [3] Group 4 - Hailier (603639.SH) shareholders plan to reduce their holdings by up to 1,200,000 shares, representing 1% of the total share capital [3] - Haotong Technology (301026.SZ) executives plan to reduce their holdings by specified amounts, with individual reductions not exceeding 20,965 to 47,250 shares [3] - Huamao Logistics (603128.SH) executives have reduced their holdings by 272,000 shares, while other executives did not reduce their holdings [3] Group 5 - Jiamei Packaging (002969.SZ) shareholders plan to reduce their holdings by a total of 9,483,239 shares, accounting for 1.00% of the total share capital [4] - Jiangsu Boyun (301003.SZ) shareholders plan to reduce their holdings by up to 971,333 shares through centralized bidding and 1,942,666 shares through block trading [4] - Jinchicken Co., Ltd. (300798.SZ) shareholders plan to reduce their holdings by 14,000,000 shares, representing 2.99% of the total share capital [4] Group 6 - Jingfang Technology (603005.SH) shareholders plan to reduce their holdings by up to 13,043,400 shares, accounting for 2% of the total share capital [5] - Jingjin Electric (688280.SH) shareholders plan to reduce their holdings through centralized bidding or block trading [5] - Kolon New Materials (920098) shareholders have not implemented reductions, while another shareholder reduced holdings by 651,667 shares, representing 0.8014% of the total share capital [5] Group 7 - Liangpinpuzi (603719.SH) shareholders plan to reduce their holdings by 4,010,000 shares, accounting for 1% of the total share capital [6] - Mike Audi (300341.SZ) executives plan to reduce their holdings by 546,350 shares, representing 0.11% of the total share capital [6] - Pinwa Food (300892.SZ) shareholders reduced their holdings by 711,300 shares, accounting for 0.72% of the total share capital [6] Group 8 - Qiu Le Seed Industry (831087.BJ) shareholders plan to reduce their holdings by up to 3,300,000 shares, representing no more than 1.9975% of the total share capital [6] - Qiu Tianwei (300939.SZ) shareholders reduced their holdings by 1,100,000 shares, accounting for 0.93% of the total share capital [6] - Rejing Bio (688068.SH) shareholders plan to reduce their holdings by 1,800,000 shares, representing 1.9416% of the total share capital [7] Group 9 - Saike Xide (688338.SH) executives plan to reduce their holdings by specified amounts, with individual reductions not exceeding 250,000 to 235,000 shares [7] - Wancheng Group (300972.SZ) executives plan to reduce their holdings through centralized bidding [7] - Wentai Technology (600745.SH) shareholders plan to reduce their holdings by up to 24,891,577 shares through block trading and 12,445,788 shares through centralized bidding [7] Group 10 - Xiechuang Data (300857.SZ) executives plan to reduce their holdings by specified amounts, with individual reductions not exceeding 10,500 to 18,900 shares [8] - Xinhongze (002836.SZ) controlling shareholder reduced holdings by 1,895,300 shares, decreasing ownership from 63.74% to 62.91% [8] - Panda Dairy (300898.SZ) shareholders reduced their holdings by 884,470 shares, accounting for 0.7133% of the total share capital [8] Group 11 - Oat Technology (688312.SH) controlling shareholder plans to reduce holdings by up to 2,912,000 shares, representing no more than 2% of the total share capital [9] - Youningwei (301166.SZ) shareholders plan to reduce their holdings by 1,208,500 shares, accounting for 1.41% of the total share capital [9] - Yuhua Tian (300815.SZ) shareholders plan to reduce their holdings by up to 23,915,520 shares, representing no more than 6.00% of the total share capital [9] Group 12 - Zhangzidao (002069.SZ) shareholders plan to reduce their holdings by up to 7,111,000 shares, accounting for no more than 1% of the total share capital [9] - Zhishang Technology (301486.SZ) shareholders reduced their holdings by 1,245,300 shares, accounting for 0.9677% of the total share capital [10] - Zhongjing Electronics (002579.SZ) shareholders plan to reduce their holdings by up to 6,000,000 shares through centralized bidding or block trading [10]

证券代码：688068 证券简称：热景生物 公告编号：2025-041 北京热景生物技术股份有限公司 关于股东减持计划完成暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 股东持有的基本情况 本次减持计划实施前，北京热景生物技术股份有限公司（以下简称"公 司"）股东青岛同程热景企业管理咨询合伙企业（有限合伙） | 股东名称 同程热景 | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 控股股东、实控人及一致行动人 | | | | | | | | √是 | | □否 | | | | 股东身份 | | | | | | | | | | | | | | 直接持股 | | 5%以上股东 | | | | □是 | | □否 | | | | | | 董事、监事和高级管理人员 | | | | | | | | | | | □是 | ...

减持计划的实施结果情况 公司于 2025 年 3 月 22 日在上海证券交易所网站（www.sse.com.cn）披露 了《北京热景生物技术股份有限公司股东减持股份计划公告》（公告编号： 2025-018）。同程热景因自身资金需求，计划通过集中竞价、大宗交易方式减持 所持有公司股份合计不超过 1,800,000 股，占公司当时总股本的 1.9465%。 证券代码：688068 证券简称：热景生物 公告编号：2025-041 北京热景生物技术股份有限公司 关于股东减持计划完成暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持有的基本情况 本次减持计划实施前，北京热景生物技术股份有限公司（以下简称"公 司"）股东青岛同程热景企业管理咨询合伙企业（有限合伙）（以下简称"同程热 景"）持有公司股份 4,211,357 股，占公司当时股份总数的 4.55%，股份来源于 公司首次公开发行前持有及资本公积转增股本取得，已上市流通。 近日，公司收到股东同程热景出具的《股份减持结果告知函》 ...

| 成交量 | 成交金额 | 成交价格 | 相对当日收盘折溢 | 买方营 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | （万股） | （万元） | （元） | 价（%） | 业部 | | | 30.00 | 3510.00 | 117.00 | -14.17 | 机构专 | 山西证券股份有限公司北京太平 | | | | | | 用 | 庄证券营业部 | | 15.00 | 1755.00 | 117.00 | -14.17 | 机构专 | 山西证券股份有限公司北京太平 | | | | | | 用 | 庄证券营业部 | | 10.09 | 1180.78 | 117.00 | -14.17 | 机构专 | 山西证券股份有限公司北京太平 | | | | | | 用 | 庄证券营业部 | | 7.20 | 842.40 | 117.00 | -14.17 | 机构专 | 山西证券股份有限公司北京太平 | | | | | | 用 | 庄证券营业部 | | 5.00 | 585.00 | 117.00 | -14.17 | 机构专 | 山西证券股份有限公司北京太平 ...

北京热景生物技术股份有限公司（以下简称"公司"）及子公司近期获得国内 医疗器械注册证/备案证 16 项，获得境外资质认证 82 项，获得化妆品备案 17 项。 相关信息如下： 证券代码：688068 证券简称：热景生物 公告编号：2025-040 北京热景生物技术股份有限公司 关于公司及子公司近期获得资质情况的自愿披露 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、获得资质的具体情况 | 序号 | 产品名称 | 注册证号 | 类别 | 发证日期 | 有效期至 | 发证机构 | | --- | --- | --- | --- | --- | --- | --- | | 1 | 吗啡头发检测试剂盒 | 国械注准 | III | 2025/05/14 | 2030/05/13 | 国家药品监督管理局 | | | （上转发光法） | 20253400943 | | | | | | 2 | β2-微球蛋白测定试剂盒 | 京械注准 | II | 2025/03/18 | 2030/03/17 | 北京市药品监督管理局 | ...

截至6月3日收盘，重组蛋白概念上涨3.64%，位居概念板块涨幅第3，板块内，45股上涨，*ST万方涨 停，诺思兰德、科兴制药、海特生物等涨幅居前，分别上涨18.82%、14.97%、13.18%。跌幅居前的有 *ST苏吴、博瑞医药、西陇科学等，分别下跌4.78%、2.48%、1.42%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 中韩自贸区 | 4.23 | 特钢概念 | -0.93 | | 细胞免疫治疗 | 3.87 | 医疗废物处理 | -0.51 | | 重组蛋白 | 3.64 | 果指数 | -0.41 | | 足球概念 | 3.56 | 无线充电 | -0.39 | | 毛发医疗 | 3.51 | 光热发电 | -0.33 | | CRO概念 | 3.41 | 深圳国企改革 | -0.24 | | 创新药 | 3.38 | F5G概念 | -0.23 | | 培育钻石 | 3.11 | 租售同权 | -0.22 | | 仿制药一致性评价 | 3.08 | 一体化压铸 | -0.21 | | 眼 ...

Company Overview - Beijing Hotgen Biotech Co., Ltd. specializes in the production of diagnostic reagents, diagnostic instruments, and biological raw materials, utilizing inner threaded copper tubes and hydrophilic aluminum foil as primary materials, which offer high heat exchange efficiency and strong corrosion resistance [1] - The company has received over 60 honors, including "Beijing Specialized and Innovative Small Giant Enterprise" and "Beijing Enterprise Technology Center," and has been recognized for its research and development achievements with multiple awards [1] Financial Performance - For Q1 2025, the company reported revenue of 93.24 million yuan, a year-on-year decrease of 19.71%, and a net loss of approximately 24 million yuan, reflecting a significant year-on-year decline of 574.96% [2] - The company's gross profit margin stands at 47.27% [2] Shareholder Information - As of March 31, 2025, the number of shareholders for Hotgen Biotech is 6,662, a decrease of 1,793 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] Market Valuation - The company's latest closing price is 124.52 yuan, with a market capitalization of 11.544 billion yuan and a price-to-book ratio of 3.87 [1] - The company's PE (TTM) is reported at -52.46, while the industry average PE is 49.65 [2]

Group 1 - The innovative drug concept stocks are experiencing a downturn, with several companies seeing declines of over 5% [1] - Notable companies affected include Sanofi, Haisun Pharmaceutical, Huisheng Biological, Rejing Biological, Haichuang Pharmaceutical, and Ruizhi Pharmaceutical [1] - Other companies such as Saiseng Pharmaceutical and Hasan Union are also following the downward trend [1]